# Lignin in Treatment of Helicobacter Pylori Infection

> **NCT07246681** · PHASE3 · ACTIVE_NOT_RECRUITING · sponsor: **Zagazig University** · enrollment: 70 (actual)

## Conditions studied

- HELICOBACTER PYLORI INFECTIONS

## Interventions

- **DRUG:** Hydrolyzed Lignin
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT07246681
- **Lead sponsor:** Zagazig University
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2025-10-31
- **Primary completion:** 2026-02-15
- **Final completion:** 2026-03-15
- **Target enrollment:** 70 (ACTUAL)
- **Last updated:** 2025-11-24

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07246681

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07246681, "Lignin in Treatment of Helicobacter Pylori Infection". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT07246681. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*